Senior insider sale
General Counsel at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$283.5K
4.08K shares
What this filing means
WAHL BRYAN plans to sell 4.08K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $283.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001959173-26-002436
Officer· General Counsel
Since Jan 2021
4.08K
Shares to sell
$283.5K
Approx. market value
4.08K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/16/2026
4.08KTotal acquired4.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/16/2026 | Restricted Stock Vesting Compensation | 4.08K | — |
| Total | 4.08K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.08K
Market value
$283.5K
3/17/2026
Total
Units
4.08K
Value
$283.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/17/2026 | 4.08K | $283.5K | NASDAQ | Planned |
| Total | 4.08K | $283.5K | ||